## Type 1 vs Type 2 Endometrial Carcinoma: Key Discriminator ### Histological Distinction **Key Point:** Type 2 (serous) carcinoma is distinguished by **high nuclear grade (Grade 3), papillary or solid growth pattern, and frequent p53 mutations**, whereas Type 1 (endometrioid) shows lower grades and glandular architecture. ### Comparative Table | Feature | Type 1 (Endometrioid) | Type 2 (Serous) | | --- | --- | --- | | **Nuclear Grade** | Low to intermediate (Grade 1–2) | High (Grade 3) | | **Growth Pattern** | Glandular, adenocarcinoma | Papillary, solid, micropapillary | | **p53 Mutation** | Rare (<10%) | Frequent (>50%) | | **Squamous Differentiation** | Common | Absent | | **Myometrial Invasion** | Variable, often superficial | Aggressive, deep | | **ER/PR Expression** | Positive | Negative or reduced | | **Molecular Pathway** | PTEN, KRAS, PIK3CA (POLE) | TP53, BRCA1/2 | | **Prognosis** | Better (Stage I: ~85% 5-yr OS) | Worse (Stage I: ~50% 5-yr OS) | ### Clinical Pearl **High-Yield:** Type 2 serous carcinomas are **aggressive despite early-stage presentation**—they frequently metastasize to the peritoneum and upper abdomen even when confined to the endometrium. This is why serous histology alone warrants staging surgery (including omentectomy and peritoneal sampling) regardless of apparent myometrial invasion depth. ### Mnemonic **SEROUS = Serious prognosis:** - **S**olid/papillary growth - **E**levated p53 mutations - **R**arely squamous - **O**ften omental spread - **U**nfavorable outcome - **S**taging surgery mandatory ### Why Squamous Differentiation Is NOT the Best Discriminator While squamous metaplasia is common in Type 1, it is **not pathognomonic** and does not occur in Type 2. However, the **absence of squamous change alone is insufficient** to diagnose Type 2—nuclear grade and growth pattern are more reliable and reproducible features across observers. [cite:Robbins 10e Ch 24]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.